- Home
- SATX vs ECOR Comparison
SATX vs ECOR Comparison
Compare SATX & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SATX
- ECOR
- Stock Information
- Founded
- SATX 2012
- ECOR 2005
- Country
- SATX Israel
- ECOR United States
- Employees
- SATX N/A
- ECOR N/A
- Industry
- SATX Radio And Television Broadcasting And Communications Equipment
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SATX Technology
- ECOR Health Care
- Exchange
- SATX Nasdaq
- ECOR Nasdaq
- Market Cap
- SATX 130.6M
- ECOR 111.3M
- IPO Year
- SATX N/A
- ECOR 2018
- Fundamental
- Price
- SATX $1.42
- ECOR $15.90
- Analyst Decision
- SATX Strong Buy
- ECOR Strong Buy
- Analyst Count
- SATX 2
- ECOR 1
- Target Price
- SATX $2.25
- ECOR $25.00
- AVG Volume (30 Days)
- SATX 461.3K
- ECOR 144.8K
- Earning Date
- SATX 02-14-2025
- ECOR 03-12-2025
- Dividend Yield
- SATX N/A
- ECOR N/A
- EPS Growth
- SATX N/A
- ECOR N/A
- EPS
- SATX N/A
- ECOR N/A
- Revenue
- SATX $10,351,000.00
- ECOR $23,327,000.00
- Revenue This Year
- SATX $80.62
- ECOR $59.81
- Revenue Next Year
- SATX N/A
- ECOR $38.49
- P/E Ratio
- SATX N/A
- ECOR N/A
- Revenue Growth
- SATX N/A
- ECOR 74.10
- 52 Week Low
- SATX $0.30
- ECOR $5.32
- 52 Week High
- SATX $2.39
- ECOR $18.67
- Technical
- Relative Strength Index (RSI)
- SATX 52.30
- ECOR 53.73
- Support Level
- SATX $1.21
- ECOR $15.50
- Resistance Level
- SATX $1.57
- ECOR $16.12
- Average True Range (ATR)
- SATX 0.33
- ECOR 1.20
- MACD
- SATX -0.04
- ECOR -0.31
- Stochastic Oscillator
- SATX 23.02
- ECOR 40.17
About SATX SatixFy Communications Ltd.
SatixFy Communications Ltd develops end-to-end next-generation satellite communications systems, including satellite payloads, user terminals and modems, based on powerful chipsets that it develops in house. Its products include modems that feature Software Defined Radio and Fully Electronically Steered Multi Beam Antennas that support the advanced communications standard DVB-S2X. Geographical presence in U.S, Canada, UK and Other countries. Majority of its company revenue comes from U.S and Canada.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.